{"DataElement":{"publicId":"3447306","version":"1","preferredName":"Uterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the uterine adenosarcoma based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3444917v1.0:3447078v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3444917","version":"1","preferredName":"Uterine Adenosarcoma Clinical N Stage","preferredDefinition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ._A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"3444913v1.0:2428496v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3444913","version":"1","preferredName":"Corpus Uteri Adenosarcoma","preferredDefinition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ.:A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","longName":"C12316:C9474","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Corpus Uteri","conceptCode":"C12316","definition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenosarcoma","conceptCode":"C9474","definition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFC61B5-2B81-B731-E040-BB89AD4344A0","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"ONEDATA","dateModified":"2012-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFC61B5-2BB3-B731-E040-BB89AD4344A0","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3447078","version":"1","preferredName":"Uterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 N Stage","preferredDefinition":"A finding about one or more characteristics of adenosarcoma, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3447078v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":"Adenosarcoma pN0 TNM Finding v7","ValueMeaning":{"publicId":"3447080","version":"1","preferredName":"Adenosarcoma pN0 TNM Finding v7","longName":"3447080","preferredDefinition":"No regional lymph node metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pN0 TNM Finding v7","conceptCode":"C89624","definition":"No regional lymph node metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-33E6-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF0DCE12-33FF-ACD4-E040-BB89AD4321A1","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"ONEDATA","dateModified":"2012-05-02","deletedIndicator":"No"},{"value":"N1","valueDescription":"Adenosarcoma pN1 TNM Finding v7","ValueMeaning":{"publicId":"3447082","version":"1","preferredName":"Adenosarcoma pN1 TNM Finding v7","longName":"3447082","preferredDefinition":"Regional lymph node metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pN1 TNM Finding v7","conceptCode":"C89625","definition":"Regional lymph node metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-340C-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF0DCE12-3425-ACD4-E040-BB89AD4321A1","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"ONEDATA","dateModified":"2012-05-02","deletedIndicator":"No"},{"value":"NX","valueDescription":"Adenosarcoma pNX TNM Finding v7","ValueMeaning":{"publicId":"3447084","version":"1","preferredName":"Adenosarcoma pNX TNM Finding v7","longName":"3447084","preferredDefinition":"Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pNX TNM Finding v7","conceptCode":"C89623","definition":"Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-3432-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF0DCE12-344B-ACD4-E040-BB89AD4321A1","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"ONEDATA","dateModified":"2012-05-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3447077","version":"1","preferredName":"Adenosarcoma TNM Finding v7 American Joint Committee on Cancer N Stage Stage","preferredDefinition":"A finding about one or more characteristics of adenosarcoma, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89606:C39315:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma TNM Finding v7","conceptCode":"C89606","definition":"A finding about one or more characteristics of adenosarcoma, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-33BA-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"ONEDATA","dateModified":"2012-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-33CB-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3444895","version":"1","longName":"Corpus Uteri Sarcoma","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777531","version":"1","longName":"Uterine Adenosarcoma","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Clinical N Stage","type":"Preferred Question Text","description":"Clinical N Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BF0F910D-4B0C-0D12-E040-BB89AD43049B","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}